The H.O.P.E. Initiative
Donation protected
Help us treat over 1,000 healthcare workers, first responders, and veterans for anxiety, depression, and sleeplessness, providing H.O.P.E. during this time of crisis.
The H.O.P.E. Initiative. Helping Our Protectors Endure. An opportunity to help more than 1,000 health workers, first responders and veterans overcome the debilitating symptoms of anxiety, depression and sleeplessness. Now, more than ever, we need to support our protectors in any way we can. Therefore, Nu-Life USA is launching this initiative to raise funds of which 100% will be used to provide symptom relief to these populations, at no cost to them, using the ground-breaking medical technology, Nu-V3, and the Nu-V3 Remote Treatment Program.
Nu-V3 is a miniaturized, wearable, non-invasive and non-pharmaceutical device, which delivers neuromodulation safely and effectively to treat pain, anxiety, depression and sleeplessness, with anxiety, depression and sleeplessness especially prevalent now. Nu-V3 works by sending a tiny electrical, micro-signal through the ear, to the brain’s nerve center, thereby treating the autonomic dysfunction or imbalance in the autonomic nervous system (ANS). This proven science of neuromodulation is the foundation of the Nu-V3 Treatment Program. The H.O.P.E. Initiative utilizes our Remote Treatment Program, which is designed to deliver the full, comprehensive Nu-V3 Treatment Program remotely and virtually.
More about The Hope Initiative. Click here
More about Nu-V3. Click here
For our FAQs. Click here
The pathway to H.O.P.E. and what your participation means. Click here
How donors can connect to patients or recipients. Click here
The Nu-V3 Remote Treatment Program is a complete, 12-month program that provides the patient with the best opportunity for short-term, as well as long-term relief from anxiety, depression, and sleeplessness, with the added benefit that treatment will be delivered virtually and remotely. The Remote Treatment Program, which we have accelerated, partly as a result of Covid-19, allows patients to have Nu-V3 delivered to their door, apply the device at home and interact virtually with our medical and clinical teams.
The H.O.P.E. Initiative is a Nu-V3 clinical trial dedicated to healthcare workers, first responders, and veterans. We can think of no better way to utilize this approval than to deliver relief to these wonderful people who put their lives on the line every day for us. A successful campaign will result in treating more than 1,000 healthcare workers, first responders, and veterans, with each patient provided with the full Nu-V3 Remote Treatment Program at no cost to them. 100% of funds raised will be dedicated to The H.O.P.E. Initiative in the United States and managed by Nu-Life USA.
Nu-Life USA is the U.S. company that provides Nu-V3 and the Nu-V3 Remote Treatment Program exclusively in the United States. Nu-Life USA is also the administrator and manager of The H.O.P.E. Initiative.
Nu-Life USA Executive Team is the leadership group that will oversee the use of all funds for The H.O.P.E. Initiative.
Nu-Life USA Executive Medical Team is the medical and clinical leadership group that will oversee all clinical operations, treatment programs, and patient care.
HOPE is what so many people are seeking at this time of crisis and stress. The challenges the world is facing in 2020 are far beyond the scope of what we envisioned. The Nu-Life team feels compelled to do what we can ASAP, to help those suffering from these debilitating symptoms, starting with our protectors.
Please help us help our protectors by supporting the H.O.P.E. Initiative and stay tuned to this page for regular updates!
The H.O.P.E. Initiative. Helping Our Protectors Endure. An opportunity to help more than 1,000 health workers, first responders and veterans overcome the debilitating symptoms of anxiety, depression and sleeplessness. Now, more than ever, we need to support our protectors in any way we can. Therefore, Nu-Life USA is launching this initiative to raise funds of which 100% will be used to provide symptom relief to these populations, at no cost to them, using the ground-breaking medical technology, Nu-V3, and the Nu-V3 Remote Treatment Program.
Nu-V3 is a miniaturized, wearable, non-invasive and non-pharmaceutical device, which delivers neuromodulation safely and effectively to treat pain, anxiety, depression and sleeplessness, with anxiety, depression and sleeplessness especially prevalent now. Nu-V3 works by sending a tiny electrical, micro-signal through the ear, to the brain’s nerve center, thereby treating the autonomic dysfunction or imbalance in the autonomic nervous system (ANS). This proven science of neuromodulation is the foundation of the Nu-V3 Treatment Program. The H.O.P.E. Initiative utilizes our Remote Treatment Program, which is designed to deliver the full, comprehensive Nu-V3 Treatment Program remotely and virtually.
More about The Hope Initiative. Click here
More about Nu-V3. Click here
For our FAQs. Click here
The pathway to H.O.P.E. and what your participation means. Click here
How donors can connect to patients or recipients. Click here
The Nu-V3 Remote Treatment Program is a complete, 12-month program that provides the patient with the best opportunity for short-term, as well as long-term relief from anxiety, depression, and sleeplessness, with the added benefit that treatment will be delivered virtually and remotely. The Remote Treatment Program, which we have accelerated, partly as a result of Covid-19, allows patients to have Nu-V3 delivered to their door, apply the device at home and interact virtually with our medical and clinical teams.
The H.O.P.E. Initiative is a Nu-V3 clinical trial dedicated to healthcare workers, first responders, and veterans. We can think of no better way to utilize this approval than to deliver relief to these wonderful people who put their lives on the line every day for us. A successful campaign will result in treating more than 1,000 healthcare workers, first responders, and veterans, with each patient provided with the full Nu-V3 Remote Treatment Program at no cost to them. 100% of funds raised will be dedicated to The H.O.P.E. Initiative in the United States and managed by Nu-Life USA.
Nu-Life USA is the U.S. company that provides Nu-V3 and the Nu-V3 Remote Treatment Program exclusively in the United States. Nu-Life USA is also the administrator and manager of The H.O.P.E. Initiative.
Nu-Life USA Executive Team is the leadership group that will oversee the use of all funds for The H.O.P.E. Initiative.
Nu-Life USA Executive Medical Team is the medical and clinical leadership group that will oversee all clinical operations, treatment programs, and patient care.
HOPE is what so many people are seeking at this time of crisis and stress. The challenges the world is facing in 2020 are far beyond the scope of what we envisioned. The Nu-Life team feels compelled to do what we can ASAP, to help those suffering from these debilitating symptoms, starting with our protectors.
Please help us help our protectors by supporting the H.O.P.E. Initiative and stay tuned to this page for regular updates!
Organizer
Nu-Life USA
Organizer
Indianapolis, IN
